Codexis completes its license transfer of its codeevolver technology to Novartis for non-exclusive use

US – Codexis, a leading enzyme engineering company enabling the promise of synthetic biology, has completed the transfer of its CodeEvolver platform technology with Novartis. The transfer comes two years later after both companies signed a platform technology transfer and license agreement, under which Novartis has a non-exclusive license to CodeEvolver to develop novel performance enzymes for use in the manufacture of pharmaceutical products. This licensing move will become the third of its kind and will have Novartis use it within its facility compared to the previous ones that had…

Read More

Merck and BioMedX set to partner as they strive to bolster their fight against cancer in a new joint cancer research programme

GERMANY – German based pharma company, Merck, and BioMed X, an independent research institute located at the University of Heidelberg in Germany have partnered to focus on their oncology related research. This is the eighth collaboration between the two organizations and is set to explore the role of extrachromosomal DNA (ecDNA) in cancer. BioMedX currently has two other ongoing oncology related programmes focused on DNA damage response and RNA splicing that this new research program is set to compliment. Extrachromosomal DNA (ecDNA) is any DNA that is found off the…

Read More

Breakthrough as phase 1 clinical malaria vaccine trial results come positive with proof to give strong lasting protection against malaria

US – The National Institute of Allergy and Infectious Diseases’ (NIAID) phase 1 clinical trials of its malaria vaccine, Sanaria (PfSPZ), have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites. Trials were conducted at the National Institutes of Health (NIH) Clinical Centre in Bethesda, Maryland led by Patrick E. Duffy, M.D., of the NIH National Institute of Allergy and Infectious Diseases (NIAID), and Stephen L. Hoffman, M.D., CEO of Sanaria Inc., Rockville, Maryland. In the CVac trials, healthy…

Read More

Technology takes center stage as companies and governments strive to digitize healthcare

WORLD – As the world goes digital and technology continues to advance, integration of vital services into the digital world is also taking shape and healthcare is top in the list as at current owing to the pandemic. According to a report by Grand View research, the global digital health market size was valued at USD 96.5 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 15.1% from 2021 to 2028. The report also noted that, increasing cases of obesity, high prevalence of…

Read More